$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > NCT02586350

安罗替尼|上市信息

安罗替尼甲状腺癌适应症获批国内上市
  • 安罗替尼甲状腺癌适应症获批国内上市
  • 1 月 4 日,NMPA 官网显示,正大天晴「安罗替尼」新适应症已经获批,其受理号为 CXHS1900040/1/2。根据此前优先审评审批的信息,本次适应症为:单药治疗无法手术的局部晚期或转移性甲...|阅读全文
  • 发布日期 2021-01-04 22:38:03